Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 15, 2016

View Archived Issues

Mayo Clinic investigates stem cell coated fistula plug in cryptoglandular perianal fistulas

Bayer initiates phase I of BAY-1862864 in relapsed or refractory CD22-positive NHL

First-in-human trial investigates GSK-3008348 for idiopathic pulmonary fibrosis

Roche starts phase I trial of anti-HBV candidate RO-7020322

Adimab announces updates on recent partnerships and development milestones

New collaboration agreements in oncology

NeuroVive enters into a strategic research partnership with University of Pennsylvania

Moderna Therapeutics outlines pipeline progress and goals for the year ahead

Kowa plans cardiovascular outcomes trial of K-877

NIH funds 24 research projects to develop non-traditional therapeutics for bacterial infections

ONO submits a manufacturing and marketing approval application for ONO-5163 in Japan

FDA issues complete response letter for BioMarin's Kyndrisa

Sanofi Pasteur will provide key funding and support to the Human Vaccines Project

Bionaturis to take part in two initiatives

New York Genome Center to investigate genetic basis of autism

BMPR1B-Fc chimera shows bone-increasing effects without toxicity

ALK reports results from trial examining Grazax in the prevention of asthma in children

Boehringer Ingelheim discloses Mdm2-p53 interaction inhibitors

Esteve announces sigma1-receptor ligands

University of Texas System patents agents for African trypanosomiasis

UNAM discloses antidepressants from Casimiroa pubescens

Katholieke Universiteit Leuven and UCB present PI4KIII-beta inhibitors

Bayer Schering Pharma announces BUB1 inhibitors

Intellia launches eXtellia to develop ex vivo gene therapies using CRISPR/Cas9 technology

Implantable synthetic converter cells, a promising strategy to treat psoriasis

PET tracer [18F]RO-6958948 shows promise to assess tau pathology in AD

Inhibition of MyD88 signaling might prevent colitis-associated colorectal cancer

FDA grants orphan drug designation to gene therapy for critical limb ischemia

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...